Haisco Pharmaceutical Group Co., Ltd.
002653
Rang in Aktien
#2072
Haisco Pharmaceutical Group Co., Ltd., along with its subsidiaries, operates... Haisco Pharmaceutical Group Co., Ltd., along with its subsidiaries, operates within China, focusing on the research, production, and distribution of a diverse range of pharmaceutical products. Their offerings span various dosage forms, including small and large volume injections, freeze-dried and conventional powder injections, and active pharmaceutical ingredients (APIs). These medications target numerous therapeutic areas such as anti-infectives, digestive system disorders, blood system conditions, nervous system ailments, parenteral nutrition, antibiotics, emergency care, anesthesiology, and oncology. Furthermore, the company provides drugs in tablet, capsule, granule, and ointment forms for cardiovascular health, infectious diseases, digestive issues, central nervous system (CNS) conditions, diabetes, and hepatic diseases. Established in 2000 and based in Shannan, China, the company adopted its current name, Haisco Pharmaceutical Group Co., Ltd., in March 2016, having previously been known as Xizang Haisco Pharmaceutical Group Co., Ltd.
Aktienkurs
$8.75
Marktkapitalisierung
$9.99B
Veränderung (1 Tag)
1.34%
Veränderung (1 Jahr)
20.35%
Land
CN
Handel Haisco Pharmaceutical Group Co., Ltd. (002653)
Kategorie
Healthcare
P/S-Verhältnis für Haisco Pharmaceutical Group Co., Ltd. (002653)
P/S-Verhältnis zum October 2026 TTM: 11.39
Laut den neuesten Finanzberichten und dem Aktienkurs von Haisco Pharmaceutical Group Co., Ltd. beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 11.39. Am Ende des Jahres 2023 lag das P/S-Verhältnis bei 7.85.
P/S-Verlauf für Haisco Pharmaceutical Group Co., Ltd. von 2008 bis 2026
P/S-Verhältnis zum Jahresende
| Jahr | P/S-Verhältnis | ändert |
|---|---|---|
| 2026 (TTM) | 11.39 | 13.83% |
| 2024 | 10.01 | 27.45% |
| 2023 | 7.85 | -1.08% |
| 2022 | 7.94 | 0.22% |
| 2021 | 7.92 | 40.72% |
| 2020 | 5.63 | 1.76% |
| 2019 | 5.53 | 55.83% |
| 2018 | 3.55 | -42.00% |
| 2017 | 6.12 | -47.45% |
| 2016 | 11.65 | -39.34% |
| 2015 | 19.20 | 26.40% |
| 2014 | 15.19 | -29.52% |
| 2013 | 21.55 | 56.97% |
| 2012 | 13.73 | 21.62% |
| 2011 | 11.29 | -1.72% |
| 2010 | 11.49 | -13.31% |
| 2009 | 13.25 | -25.65% |
| 2008 | 17.82 | 0.00% |
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | P/S-Verhältnis | P/S-Verhältnis-Differenz | Land |
|---|---|---|---|
| 10.02 | -12.04% |
US
|
|
| 40.55 | 255.89% |
US
|
|
| 3.96 | -65.24% |
AU
|
|
| - | - |
CH
|
|
| 10.15 | -10.95% |
NL
|
